Subscribe To Our Free Newsletter |
Piramal Pharma gains as Q4 PAT doubles to Rs 101 crore
Piramal Pharma advanced 2.69% to Rs 154.35 after the pharmaceutical company reported a consolidated net profit surged 102.1% to Rs 101.27 crore in Q4 FY24 as against Rs 50.11 crore posted in Q4 FY23.